March 1, 2022—The National Home Infusion Foundation (NHIF) announces the finalists for its the Outstanding Abstract Achievement Award for 2022. The authors of the following 6 poster abstracts will give a short (10-15 minute) podium presentation providing an overview of the research project and summarizing their findings during a special clinical track session at the Annual Conference and a panel of judges will select the award recipient. Posters examine innovative approaches to clinical practice, identify an opportunity or best practice, or demonstrate quality improvement within the home and alternate site infusion industry.

• Adherence of Patients Receiving Immunoglobulin Replacement Therapy in the Home during the Novel Coronavirus 2019 Pandemic 
  Loretta Kristofek, RN, BSN
  Coram/CVS Specialty Infusion

• Reduction of Microbes and Hazardous Drug Residues on IV Bags with a Sporicidal Disinfectant
  Kenneth M. Wiencek, PhD
  Contec, Inc.

• Utility of Olive-Oil Based Lipid Emulsion as an Alternative Fatty Acid Source in Parenteral Nutrition Patients
  Jake Burkhalter, PharmD
  Chartwell Pennsylvania, LP

• An Investigation on Empiric Vancomycin Dose Reduction in Home Infusion to Optimize Patient Safety
  Cheyenne D. Johnson, PharmD
  Option Care Health

• The Safety of Natalizumab Administration in the Home during the COVID-19 Pandemic for Patients with Multiple Sclerosis
  Rohae Musa, PharmD
  Option Care Health

• Therapy Optimization and Clinical Interventions within a Specialty Infusion Pharmacy Lead to Significant Direct and Indirect Cost Savings
  Barbara Prosser, RPh
  Soleo Health

Don’t miss the finalists’ presentations on Monday, March 14 (11:00 – 12:00) and the award presentation at the General Session on Tuesday, March 15 (9:45 – 11:15).

Download Announcement (pdf)